Bolt Biotherapeutics
BOLT
BOLT
34 hedge funds and large institutions have $25.5M invested in Bolt Biotherapeutics in 2023 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 8 increasing their positions, 7 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
75% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 8
Holders
34
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$232K | |
| 2 | +$131K | |
| 3 | +$39.1K | |
| 4 |
NM
Newtyn Management
New York
|
+$20.8K |
| 5 |
Squarepoint
New York
|
+$16.7K |
Top Sellers
| 1 | -$364K | |
| 2 | -$203K | |
| 3 | -$177K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$138K |
| 5 |
Millennium Management
New York
|
-$71.8K |